Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004224621 | SCV003731452 | uncertain significance | Cardiovascular phenotype | 2024-01-29 | criteria provided, single submitter | clinical testing | The p.P1190L variant (also known as c.3569C>T), located in coding exon 26 of the JAG1 gene, results from a C to T substitution at nucleotide position 3569. The proline at codon 1190 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003509774 | SCV004308471 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2023-02-27 | criteria provided, single submitter | clinical testing |